Editorial: Targeting the interleukin-1β/interleukin-6/C-reactive protein pathway in clinical medicine - a road map to clinical trial design.
Saved in:
| Title: | Editorial: Targeting the interleukin-1β/interleukin-6/C-reactive protein pathway in clinical medicine - a road map to clinical trial design. |
|---|---|
| Authors: | Torzewski J; Department of Cardiology, Cardiovascular Center Oberallgaeu-Kempten, Clinic Association Allgaeu, Kempten, Germany., Sheriff A; Medical Department, Charité University Medicine, Berlin, Germany., Filep JG; Department of Pathology and Cell Biology, University of Montreal, Montreal, QC, Canada., Peter K; Department of Cardiometabolic Health, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia., Ridker PM; Heart and Vascular Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States. |
| Source: | Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2025 Jun 26; Vol. 12, pp. 1644576. Date of Electronic Publication: 2025 Jun 26 (Print Publication: 2025). |
| Publication Type: | Editorial |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101653388 Publication Model: eCollection Cited Medium: Print ISSN: 2297-055X (Print) Linking ISSN: 2297055X NLM ISO Abbreviation: Front Cardiovasc Med Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
